Harvard Dermatopathology Update 2024

Overview

Harvard Dermatopathology Update 2024 is a comprehensive digital on-demand course delivering the latest advances in dermatopathology. This program covers new diagnostic criteria, molecular diagnostics, tumor staging integration, and clinical pathological correlation in inflammatory and neoplastic skin diseases.

On-demand dermatology education — accessible anytime, anywhere.

Agenda

This course offers a detailed multi-day agenda featuring expert presentations focused on practical and current topics in dermatopathology.

• Welcome and Introduction
• Predictive Dermatopathology: Toward more precise assessment of progression risk and therapeutic efficacy in human melanoma — George F. Murphy, MD
• Cutaneous T cell lymphoma (CTCL) and mimics — Lyn Duncan, MD
• Cutaneous B cell neoplasms — Judith Ferry, MD
• Cutaneous Fibrosing Disorders — Rosalynn Nazarian, MD
• An Approach to Quality and Safety in Dermatopathology: Quality Improvement and Workflow Redesign — Mia S. DeSimone, MD, MPH
• Expert Panel — Lyn Duncan, MD; Mai Hoang, MD; George F. Murphy, MD; Steven Tahan, MD; Julia Lehman, MD
• New Insights into Lesions We Thought We Knew — Steven Tahan
• Pediatric Dermatopathology — Birgitta Schmidt, MD
• New diagnostic criteria for oral leukoplakias — Sook-Bin Woo, DMD
• Practical pearls in autoimmune connective tissue diseases — Julia Lehman, MD
• Challenging cases of immunobullous diseases — Julia Lehman, MD
• Inflammatory Vulvar Lesions — Ashley Ward, MD
• HPV-Negative Squamous Vulvar Lesions — Jaclyn Watkins, MD
• Updates in Adnexal Neoplasms — Eleanor Russell-Goldman, MD, PhD
• Cutaneous Mesenchymal Tumors: Morphology and Molecular Correlates — Ivan Chebib, MD
• Pearls and Pitfalls in the diagnosis of cutaneous mycobacterial infections — Alvaro Laga Canales, MD, MSc
• Practical approach to difficult melanocytic tumors — Christine G. Lian, MD
• Squamous Penile Lesions — Kristine Cornejo, MD
• Eye Pathology of Pigmented Lesions — Anna Stagner, MD
• ALK+ cutaneous neoplasms — Ruth Foreman, MD, PhD

Learning Objectives

Upon completion of this activity, participants will be able to:

• Discuss new criteria for pathologic diagnoses, including molecular diagnostics.
• Integrate modern staging systems for tumors into clinical practice.
• Evaluate and distinguish cutaneous neoplasms including melanocytic, squamous, and lymphoid from mimics.
• Apply clinical pathologic correlation in evaluating inflammatory dermatoses.

Speakers

• George F. Murphy, MD
• Lyn Duncan, MD
• Judith Ferry, MD
• Rosalynn Nazarian, MD
• Mia S. DeSimone, MD, MPH
• Mai Hoang, MD
• Steven Tahan, MD
• Julia Lehman, MD
• Birgitta Schmidt, MD
• Sook-Bin Woo, DMD
• Ashley Ward, MD
• Jaclyn Watkins, MD
• Eleanor Russell-Goldman, MD, PhD
• Ivan Chebib, MD
• Alvaro Laga Canales, MD, MSc
• Christine G. Lian, MD
• Kristine Cornejo, MD
• Anna Stagner, MD
• Ruth Foreman, MD, PhD

This course was originally delivered as a live multi-day event and is now accessible on-demand, providing dermatopathology expertise without time constraints.

Target Audience

This course is designed for dermatologists, pathologists, dermatopathologists, and other healthcare professionals involved in cutaneous disease diagnosis and management who seek to enhance their expertise with current dermatopathology practices.

Why This Topic Matters

Harvard Dermatopathology Update 2024 addresses essential advancements in dermatopathology, offering critical insights for clinicians and pathologists. The knowledge shared supports improved diagnostic accuracy and integration of evolving molecular techniques relevant to dermatology and pathology.

MedHub Central provides this program to strengthen professional confidence and clinical skills in dermatopathology, emphasizing its sustained relevance in patient care and cutting-edge academic practice.